Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
   J01 ANTIBACTERIALS FOR SYSTEMIC USE
   J02 ANTIMYCOTICS FOR SYSTEMIC USE
   J04 ANTIMYCOBACTERIALS
     J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
       J04AA Aminosalicylic acid and derivatives
       J04AB Antibiotics
         J04AB01 Cycloserine
         J04AB02 Rifampicin [DG:DG00639]
         J04AB03 Rifamycin [DG:DG00640]
         J04AB04 Rifabutin
         J04AB05 Rifapentine
           D00879  Rifapentine (USAN/INN) <US>
         J04AB06 Enviomycin [DG:DG01219]
         J04AB30 Capreomycin [DG:DG00641]
       J04AC Hydrazides
       J04AD Thiocarbamide derivatives
       J04AK Other drugs for treatment of tuberculosis
       J04AM Combinations of drugs for treatment of tuberculosis
     J04B DRUGS FOR TREATMENT OF LEPRA
   J05 ANTIVIRALS FOR SYSTEMIC USE
   J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J07 VACCINES
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: April 16, 2024
According to WHO's ATC 2024

» Japanese version